STEPHEN A HILL
CIK 1237404 · President, CEO · last filed 2020-12-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.9K
Companies
5
Total Filings
38
Lifetime Open-Market Net
$82.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LPCN | Director | 750 | $2.14 | $1.6K | $15.5K | 9 | 2020-12-17 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Director | 18,000 | $0.12 | $2.1K | $17.2K | 6 | 2020-06-25 |
| CBIO | Director | 79 | $16.44 | $1.3K | $10.1K | 9 | 2018-09-06 |
| Cellectar Biosciences, Inc. (CLRB.W) Delisted | Director | 5,300 | — | — | $19.9K | 4 | 2016-07-06 |
| Cellectar Biosciences, Inc. (CLRB.Z) Delisted | Director | 9,920 | — | — | $19.9K | 1 | 2016-04-21 |
Recent Filings · Page 2 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-06-15 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2018-02-22 | CBIO | Other (J) | — | $0 | EDGAR |
| 2018-01-02 | LPCN | Mixed | +1,250 | -$4.3K | EDGAR |
| 2017-07-14 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2017-06-01 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-30 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2016-07-06 | Cellectar Biosciences, Inc. (CLRB.W) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-06-17 | LPCN | Grant (A) | — | $0 | EDGAR |
| 2016-06-13 | CBIO | Grant (A) | — | $0 | EDGAR |
| 2016-04-21 | Cellectar Biosciences, Inc. (CLRB.Z) Delisted | Buy (P) | +9,390 | $19.9K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.